Pınar Tolunay-Kubilay

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Liquid biopsy for biliary tract cancer: available evidence and future research directions.

Liquid biopsy for biliary tract cancer: available evidence and future research directions.

Journal: Expert review of molecular diagnostics

Published: May 06, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

Journal: Medicina (Kaunas, Lithuania)

Published: April 15, 2026

Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps.

Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps.

Journal: Drug design, development and therapy

Published: December 10, 2025

Re: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial.

Re: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial.

Journal: ESMO open

Published: July 12, 2025

Chemotherapy tolerance and continuity are prognostic for overall survival in patients with localized and advanced biliary tract cancer.

Chemotherapy tolerance and continuity are prognostic for overall survival in patients with localized and advanced biliary tract cancer.

Journal: Turkish journal of medical sciences

Published: May 02, 2025

Comparison of AI chatbot predicted and realworld survival outcomes in hepatocellular carcinoma.

Comparison of AI chatbot predicted and realworld survival outcomes in hepatocellular carcinoma.

Journal: Scientific reports

Published: February 21, 2025

A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy.

A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy.

Journal: Medicina (Kaunas, Lithuania)

Published: January 20, 2025

Timing of Dose Reductions and Survival Outcomes in Metastatic Breast Cancer Patients Treated with Cyclin-Dependent Kinase 4/6 Inhibitors.

Timing of Dose Reductions and Survival Outcomes in Metastatic Breast Cancer Patients Treated with Cyclin-Dependent Kinase 4/6 Inhibitors.

Journal: Current oncology (Toronto, Ont.)

Published: October 16, 2024

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.

Journal: Current oncology (Toronto, Ont.)

Published: July 29, 2024

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer.

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer.

Journal: Tuberkuloz ve toraks

Published: July 05, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026